Lung volume reduction surgery (LVRS) is a treatment for end-stage lung disease caused by emphysema. Emphysema is a type of chronic obstructive pulmonary disease (COPD) that causes shortness of breath ...

Current evidence on the efficacy of living-donor lung transplantation for end-stage lung disease and its safety profile for suitable recipients appears adequate to support the use of this procedure.

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Patients with systemic autoimmune rheumatic disease who develop interstitial lung disease ...

Emerging insights into the gut-lung axis continue to open new possibilities for managing chronic respiratory diseases, from cystic fibrosis (CF) in the youngest patients to chronic obstructive ...

Thermo Fisher Scientific has launched a new diagnostic test to help physicians better detect and manage lung transplant rejection. Dubbed the Molecular Microscope Diagnostic System for Lung, the test ...

Evidence-based recommendations on living-donor lung transplantation for end-stage lung disease. This involves removing a lung from each of the two donors and replacing the recipient's lungs with the ...